deltatrials
Terminated NA INTERVENTIONAL 1-arm NCT05299177

Feasibility of Automated Insulin Delivery With an Interoperable Algorithm Using an Alternative Insulin Pump (BELIEVE)

Sponsor: DexCom, Inc.

Conditions Type 1 Diabetes
Interventions InControl
Updated 5 times since 2022 Last updated: Sep 1, 2025 Started: Apr 1, 2022 Primary completion: Aug 31, 2025 Completion: Aug 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study device not available

Other terminated trials from DexCom, Inc.

More terminations from DexCom, Inc.

Other Type 1 Diabetes trials with similar outcome

Browse all Type 1 Diabetes trials

A NA clinical study on Type 1 Diabetes, this trial is terminated or withdrawn. The trial is conducted by DexCom, Inc. and has accumulated 5 data snapshots since 2022. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

~Apr 2022 – ~Sep 2022 · 5 months · monthly snapshotNot Yet Recruiting~Sep 2022 – ~Jul 2024 · 22 months · monthly snapshotRecruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Oct 2025 · 13 months · monthly snapshotUnknown~Oct 2025 – present · 11 months · monthly snapshotTerminated

Change History

5 versions recorded

  1. Oct 2025 — Present [monthly]

    Terminated NA

    Status: Unknown → Terminated

  2. Sep 2024 — Oct 2025 [monthly]

    Unknown NA

    Status: Recruiting → Unknown

  3. Jul 2024 — Sep 2024 [monthly]

    Recruiting NA

  4. Sep 2022 — Jul 2024 [monthly]

    Recruiting NA

    Status: Not Yet Recruiting → Recruiting

  5. Apr 2022 — Sep 2022 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • DexCom, Inc.
  • Imperial College London
Data source: Imperial College London

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations